Argyle Capital Partners, LLC

Position in PFE — Pfizer Inc

CIK 2079995 LOS ANGELES, CA

Position in PFE

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$322,936

-$84,504 QoQ

Shares Held

13,411

-7.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.35%

of 13F equity value

Holder Rank

#2,077

of 2,821 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 93% Shared 7% None 0%

Healthcare · as of Jun 30, 2026

Argyle Capital Partners, LLC holds $5,444,856 across 5 Drug Manufacturers - General names. PFE ranks #5 (5.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	9,306	$2,341,761
2	AMGN	Amgen Inc	4,851	$1,756,643
3	NVS	Novartis AG	4,094	$641,611
4	BMY	Bristol Myers Squibb Co	6,628	$381,905
5	PFE	Pfizer Inc This page	13,411	$322,936

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$322,936	13,411	-7.6%	Shares	Sole	2026-08-07
2026-03-31	$407,440	14,510	+4.4%	Shares	Sole	2026-05-07
2025-12-31	$346,209	13,904	+10.0%	Shares	Sole	2026-02-17
2025-09-30	$322,143	12,643	-9.5%	Shares	Sole	2025-11-14
2025-06-30	$338,705	13,973	+13.7%	Shares	Sole	2025-08-13
2025-03-31	$311,352	12,287	-12.7%	Shares	Sole	2025-08-13
2024-12-31	$373,595	14,082	—	Shares	Sole	2025-08-13
No filing history on record for this holder in this stock.